Estimating Inhaled Corticosteroid Exposure from Short-Acting β₂-Agonist–Inhaled Corticosteroid Rescue

Njira Lugogo1 Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA

https://orcid.org/0000-0002-0235-7105 View further author information

Ileen Gilbert2 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA

https://orcid.org/0000-0003-3529-0186 View further author information

Michael Pollack2 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USACorrespondence[email protected]

https://orcid.org/0000-0001-7351-3059 View further author information

Hitesh Gandhi2 BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA

https://orcid.org/0000-0001-7729-0171 View further author information

Joseph Tkacz3 Inovalon, Bowie, MD, USA

https://orcid.org/0000-0003-2369-356X View further author information

Miguel J Lanz4 Allergy and Asthma, AAADRS Clinical Research Center, Coral Gables, FL, USA

https://orcid.org/0000-0002-2868-5596 View further author information

References

Quint JK, Arnetorp S, Kocks JWH, et al. Short-acting beta-2-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. J Allergy Clin Immunol Pract. 2022;10(9):2297–2309. doi:10.1016/j.jaip.2022.02.047
PubMed Web of Science ®Google Scholar
Heatley H, Tran TN, Bourdin A, et al. Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax. 2022. doi:10.1136/thorax-2022-219642
PubMed Web of Science ®Google Scholar
Global Initiative for Asthma. Global strategy for asthma management and prevention, 2023. Updated May 2023. Available from: https://ginasthma.org. Accessed May 18, 2023.
Google Scholar
National Heart, Lung, and Blood Institute (NHLBI). Guidelines for the Diagnosis and Management of Asthma (EPR3 & Focused Update). Available from: https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma. Accessed May 18, 2023.
Google Scholar
Papi A, Chipps BE, Beasley R, et al. Albuterol-budesonide fixed-dose combination rescue inhaler for asthma. N Engl J Med. 2022;386(22):2071–2083. doi:10.1056/NEJMoa2203163
PubMed Web of Science ®Google Scholar
Israel E, Cardet JC, Carroll JK, et al. Reliever-triggered inhaled glucocorticoid in black and latinx adults with asthma. N Engl J Med. 2022;386(16):1505–1518. doi:10.1056/NEJMoa2118813
PubMed Web of Science ®Google Scholar
Daley-Yates PT. Inhaled corticosteroids: potency, dose equivalence and therapeutic index. Br J Clin Pharmacol. 2015;80(3):372–380. doi:10.1111/bcp.12637
PubMed Web of Science ®Google Scholar

Estimating Inhaled Corticosteroid Exposure from Short-Acting β₂-Agonist–Inhaled Corticosteroid Rescue

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Estimating Inhaled Corticosteroid Exposure from Short-Acting β₂-Agonist–Inhaled Corticosteroid Rescue